{"title": "US sinks another $2.1 billion into a potential vaccine", "author": "DANICA KRKA Associated Press", "url": "https://katv.com/news/coronavirus/us-sinks-another-21-billion-into-a-potential-vaccine", "hostname": "katv.com", "description": "LONDON (AP) \u2014 Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2. 1 billion \"for development including clinical trials, manufacturing, scale-up and delivery\" of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds. The U. S.", "sitename": "KATV", "date": "2020-07-31", "cleaned_text": "US sinks another $2.1 billion into a potential vaccine by DANICA KRKA Associated Press In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England Thursday June 25, 2020. (John Cairns, University of Oxford via AP) "}